You are here: Industry Insights > OTC

News List

Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns fiercepharma
August 22, 2017
Dr. Reddy's is reviving the once well-known OTC back pain relief brand Doan's with a national TV and digital push.
NHS England takes tough stance on homeopathy pharmafile
July 25, 2017
Homeopathy is one of the most controversial subjects within the healthcare system and NHS England has outlined its stance by proposing cutting funding to the medicine.
Fresenius Kabi Acquires Akorn in $4.3bn Deal contractpharma
April 27, 2017
Strategically complementary combination to enhance and diversify Fresenius Kabi’s business and portfolio
Purdue Pharma Announces Hire of Carrie Chomiak to Lead OTC Franchise americanpharmaceuticalreview
April 24, 2017
Purdue Pharma L.P. announced the hire of Carrie Chomiak as the business lead for the company’s over-the-counter (OTC) product franchise.
Sanofi's Xyzal® Allergy 24HR Approved for OTC Use in the United States americanpharmaceuticalreview
February 06, 2017
Sanofi has announced that the U.S. Food and Drug Administration (FDA) approved Xyzal® Allergy 24HR as an over-the-counter (OTC) treatment for the relief of symptoms associated with seasonal and year-round allergies.
Sanofi's Xyzal Allergy 24HR approved for OTC use in the US cphi-online
February 06, 2017
FDA has approved Sanofi's Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the relief of symptoms associated with seasonal and year-round allergies. Xyzal is an oral antihistamine with a proven 24-hour effect.

Previous page 1 2 3 4 5 6 Next page